Open AccessS1166 Serum Creatinine ≥ 5 mg/dL Is Associated With Decreased Safety and Efficacy in Patients Treated With Terlipressin for Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) in the United Kingdom (UK)
Author(s) -
Andrew S. Allegretti,
Khurram Jamil,
Katharina Verleger,
Shelby Corman,
Nehemiah Kebede,
Sneha S. Kelkar,
Marieke Heisen,
Xingyue Huang,
Kevin Moore
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000778196.97054.f8
Subject(s) - medicine , terlipressin , hepatorenal syndrome , creatinine , acute kidney injury , clinical endpoint , adverse effect , incidence (geometry) , renal function , clinical trial , cirrhosis , physics , optics